DK2342197T3 - Radiomærkede inhibitorer af glycin 1-transportør - Google Patents

Radiomærkede inhibitorer af glycin 1-transportør

Info

Publication number
DK2342197T3
DK2342197T3 DK09737459.9T DK09737459T DK2342197T3 DK 2342197 T3 DK2342197 T3 DK 2342197T3 DK 09737459 T DK09737459 T DK 09737459T DK 2342197 T3 DK2342197 T3 DK 2342197T3
Authority
DK
Denmark
Prior art keywords
glycin
radio
transport
labeled inhibitors
inhibitors
Prior art date
Application number
DK09737459.9T
Other languages
English (en)
Inventor
Daniela Alberati
Thomas Hartung
Roger Norcross
Emmanuel Pinard
Edilio Maurizio Borroni
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK2342197T3 publication Critical patent/DK2342197T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK09737459.9T 2008-11-04 2009-10-26 Radiomærkede inhibitorer af glycin 1-transportør DK2342197T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08168229 2008-11-04
PCT/EP2009/064033 WO2010052143A1 (en) 2008-11-04 2009-10-26 Radiolabelled inhibitors of the glycine 1 transporter

Publications (1)

Publication Number Publication Date
DK2342197T3 true DK2342197T3 (da) 2013-02-18

Family

ID=41402176

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09737459.9T DK2342197T3 (da) 2008-11-04 2009-10-26 Radiomærkede inhibitorer af glycin 1-transportør

Country Status (21)

Country Link
US (1) US8153679B2 (da)
EP (1) EP2342197B1 (da)
JP (1) JP5543477B2 (da)
KR (1) KR101307671B1 (da)
CN (1) CN102186844B (da)
AR (1) AR074084A1 (da)
AU (1) AU2009312891B2 (da)
BR (1) BRPI0921795B8 (da)
CA (1) CA2739869C (da)
CL (1) CL2011000982A1 (da)
DK (1) DK2342197T3 (da)
ES (1) ES2401221T3 (da)
IL (1) IL211804A (da)
MX (1) MX2011004350A (da)
PE (1) PE20110434A1 (da)
PL (1) PL2342197T3 (da)
RU (1) RU2512529C2 (da)
SI (1) SI2342197T1 (da)
TW (1) TWI449537B (da)
WO (1) WO2010052143A1 (da)
ZA (1) ZA201102521B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5618047B2 (ja) * 2010-01-29 2014-11-05 国立大学法人千葉大学 ポジトロン断層撮影法およびポジトロン放出化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100774622B1 (ko) 2003-08-11 2007-11-08 에프. 호프만-라 로슈 아게 Ｏｒ-치환된 페닐 그룹을 갖는 피페라진 및 ｇｌｙｔ1억제제로서 그의 용도
EP1848694B1 (en) * 2005-02-07 2009-11-25 F. Hoffmann-Roche AG Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
WO2007041025A2 (en) * 2005-09-29 2007-04-12 Merck & Co., Inc. Radiolabeled glycine transporter inhibitors

Also Published As

Publication number Publication date
KR20110063861A (ko) 2011-06-14
BRPI0921795A2 (pt) 2016-01-12
US8153679B2 (en) 2012-04-10
BRPI0921795B1 (pt) 2020-10-20
WO2010052143A1 (en) 2010-05-14
PL2342197T3 (pl) 2013-06-28
PE20110434A1 (es) 2011-07-01
TWI449537B (zh) 2014-08-21
ES2401221T3 (es) 2013-04-17
EP2342197A1 (en) 2011-07-13
CA2739869C (en) 2016-09-27
TW201019964A (en) 2010-06-01
JP2012507486A (ja) 2012-03-29
MX2011004350A (es) 2011-05-23
IL211804A (en) 2013-11-28
AU2009312891A1 (en) 2010-05-14
EP2342197B1 (en) 2013-01-16
BRPI0921795B8 (pt) 2021-07-27
US20100111862A1 (en) 2010-05-06
CA2739869A1 (en) 2011-05-14
AR074084A1 (es) 2010-12-22
SI2342197T1 (sl) 2013-05-31
RU2512529C2 (ru) 2014-04-10
KR101307671B1 (ko) 2013-09-12
CN102186844A (zh) 2011-09-14
ZA201102521B (en) 2012-09-29
RU2011118230A (ru) 2012-12-20
CL2011000982A1 (es) 2012-02-03
CN102186844B (zh) 2014-08-13
JP5543477B2 (ja) 2014-07-09
AU2009312891B2 (en) 2013-07-11
IL211804A0 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
CY2020024I2 (el) Αναστολεiς βητα-λακταμασων
CY2017016I2 (el) Αναστολεις πρωτεασωματος
SMT201600267B (it) Inibitori di syk imidazopirazinici
DK3208269T3 (da) Inhibitorer af c-fms-kinase
BR112012006686A2 (pt) composto amida substituído
DK2262793T3 (da) Krystallinske former af nilotinib-hci
ATE478849T1 (de) 4-anilinochinolin-3-carbonsäureamide als csf-1r- kinaseinhibitoren
DE112009001515A5 (de) Befestigungsbinder
DK2219469T3 (da) Modificering af enzymatisk disponerede proteiner
BRPI0906705A2 (pt) Composto heterocíclicos
SMT201500157B (it) Pirazolilaminopiridine come inibitori di fak
DK2111555T3 (da) Diagnosticering af præeklampsi
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
BRPI0918564A2 (pt) inibidores
IT1391986B1 (it) Ciabatta di tipo perfezionato
FR2921662B1 (fr) Polyamide de haute fluidite
SMT201600031B (it) Composti eterociclici di fenossimetile
DK2114147T3 (da) Reduktion af bivirkninger af tramadol
DK2506840T3 (da) Anvendelser af hæmmere af hypoksi-fremkaldende faktorer
DK2041088T3 (da) Glycintransporter-1 inhibitorer
FR2899232B1 (fr) Polyamide de haute fluidite
DK2240433T3 (da) Polymorfe former af oseltamivir-phosphat
DK2342197T3 (da) Radiomærkede inhibitorer af glycin 1-transportør
UA16153S (uk) Пляшка фірмова
UA18744S (uk) Комплект етикеток